This document provides information on pneumococcal conjugate vaccine (PCV) safety and adverse event following immunization (AEFI) surveillance. It states that PCV is known to be safe with minor and rare AEFIs reported like fever, injection site reactions. It outlines the classification, reporting timelines and roles for minor, severe and serious AEFIs. The last section provides an overview of PCV AEFI reporting from various Indian states from 2011-2021 with most cases reported from Bihar, Uttar Pradesh and Madhya Pradesh.